Clinical Trial of Mica

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

6,800

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

August 31, 2027

Conditions
Latent Tuberculosis Infection
Interventions
BIOLOGICAL

Mycobacterium Vaccae for Injection

The experimental group was alternately injected with 1 dose of microcard every two weeks (0-2-4-6-8-10 weeks) in the left and right hip muscle deep, and a total of 6 doses were injected.

Trial Locations (2)

545000

Liujiang district Prevention and Control center, Liuzhou

Liuzhou Center for Disease Control and Prevention, Liuzhou

All Listed Sponsors
lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY